Patent details

Basic Information

Publication number:

EP3406631

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181690496

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES

French Title of Invention:

LIGNES DE CELLULES TUEUSES NATURELLES HUMAINES MODIFIÉES GÉNÉTIQUEMENT

German Title of Invention:

GENETISCH MODIFIZIERTE HUMANE NATÜRLICHE KILLERZELLENLINIEN

SPC Number:

Dates

Filing date:

08/07/2005

Grant date:

29/06/2022

EP Publication Date:

28/11/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/06/2022

EP B1 Publication Date:

29/06/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/07/2022

Expiration date:

08/07/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/06/2022

 

 

Name:

The Institute for Cancer Research

Address:

333 Cottman Avenue, Philadelphia, PA 19111, United States (US)

Inventor

Name:

CAMPBELL, Kerry S.

Address:

United States (US)

Priority

Priority Number:

586581 P

Priority Date:

10/07/2004

Priority Country:

United States (US)

Classification

IPC classification:

C07K 14/705; C12N 5/00; C07K 16/32; A61K 39/395; A61K 49/00; A61K 35/17; C07K 14/735; C07K 16/28; C12N 5/0783; G01N 33/50; A61K 35/12;

Publication

European Patent Bulletin

Issue number:

202226

Publication date:

29/06/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages